ATProto Browser

{
  "text": "0 day turnover for peer review is super-sketch: “A 2018 JPAD article suggested that pimavanserin, a drug to treat psychosis among Alzheimer’s patients, was effective. The manuscript cleared peer review the same day JPAD editors received it.”\nretractionwatch.com/2025/02/04/u...",
  "$type": "app.bsky.feed.post",
  "embed": {
    "$type": "app.bsky.embed.external",
    "external": {
      "uri": "https://retractionwatch.com/2025/02/04/undisclosed-conflicts-lightning-fast-peer-review-one-alzheimers-journals-role-in-a-failed-drug/",
      "thumb": {
        "$type": "blob",
        "ref": {
          "$link": "bafkreico2yujwyt2uvzg3se3b7wx6uuqsz6umwvgbfmeq6vadxv5nl52ii"
        },
        "mimeType": "image/jpeg",
        "size": 23204
      },
      "title": "Undisclosed conflicts, lightning-fast peer review: One Alzheimer’s journal’s role in a failed drug",
      "description": "Retraction Watch readers are likely familiar with the work of Charles Piller, an award-winning investigative reporter who has been covering problematic research in neuroscience and other fields for…"
    }
  },
  "langs": [
    "en"
  ],
  "facets": [
    {
      "index": {
        "byteEnd": 283,
        "byteStart": 248
      },
      "features": [
        {
          "uri": "https://retractionwatch.com/2025/02/04/undisclosed-conflicts-lightning-fast-peer-review-one-alzheimers-journals-role-in-a-failed-drug/",
          "$type": "app.bsky.richtext.facet#link"
        }
      ]
    }
  ],
  "createdAt": "2025-02-05T05:57:30.339Z"
}